9.14
price down icon4.44%   -0.33
after-market 시간 외 거래: 9.14
loading
전일 마감가:
$9.47
열려 있는:
$9.36
하루 거래량:
460.18K
Relative Volume:
2.72
시가총액:
$468.78M
수익:
-
순이익/손실:
$-76.41M
주가수익비율:
-4.57
EPS:
-2
순현금흐름:
$-64.56M
1주 성능:
-18.76%
1개월 성능:
-22.91%
6개월 성능:
+24.48%
1년 성능:
+11.73%
1일 변동 폭
Value
$9.03
$9.785
1주일 범위
Value
$9.05
$11.22
52주 변동 폭
Value
$6.63
$12.38

Aura Biosciences Inc Stock (AURA) Company Profile

Name
명칭
Aura Biosciences Inc
Name
전화
(617)500-8864
Name
주소
80 GUEST STREET, BOSTON
Name
직원
89
Name
트위터
Name
다음 수익 날짜
2024-08-07
Name
최신 SEC 제출 서류
Name
AURA's Discussions on Twitter

AURA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
AURA 9.14 468.78M 0 -76.41M -64.56M -2.00
VRTX 467.12 119.83B 10.63B -479.80M -1.35B 13.33
REGN 762.38 83.28B 13.85B 4.65B 3.32B 35.06
ARGX 567.35 33.74B 1.86B -40.29M -1.28B -4.16
ALNY 232.27 30.38B 2.09B -332.26M 16.06M -4.14
BNTX 101.83 24.08B 3.30B -501.07M 1.03B 11.54

Aura Biosciences Inc Stock (AURA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-07-27 개시 Scotiabank Sector Outperform
2023-04-17 재개 BTIG Research Buy
2022-07-19 개시 JMP Securities Mkt Outperform

Aura Biosciences Inc 주식(AURA)의 최신 뉴스

pulisher
03:23 AM

HC Wainwright Forecasts Higher Earnings for Aura Biosciences - Defense World

03:23 AM
pulisher
Nov 17, 2024

Aura Biosciences, Inc. (NASDAQ:AURA) Short Interest Up 7.6% in October - MarketBeat

Nov 17, 2024
pulisher
Nov 17, 2024

Aura Biosciences’ (AURA) Buy Rating Reiterated at HC Wainwright - Defense World

Nov 17, 2024
pulisher
Nov 16, 2024

What is Leerink Partnrs’ Estimate for AURA FY2024 Earnings? - Defense World

Nov 16, 2024
pulisher
Nov 15, 2024

Research Analysts Set Expectations for AURA FY2024 Earnings - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Citadel Advisors LLC Reduces Stake in Aura Biosciences Inc - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

Brokerages Set Aura Biosciences, Inc. (NASDAQ:AURA) Target Price at $23.00 - Defense World

Nov 15, 2024
pulisher
Nov 14, 2024

HC Wainwright Reaffirms Buy Rating for Aura Biosciences (NASDAQ:AURA) - MarketBeat

Nov 14, 2024
pulisher
Nov 13, 2024

Aura Biosciences Reports Q3 Financial Results - TipRanks

Nov 13, 2024
pulisher
Nov 13, 2024

Aura Stock Up as Lead Drug Shows Superior Efficacy in Eye Cancer Study - MSN

Nov 13, 2024
pulisher
Nov 12, 2024

Aura Biosciences : Reports Third Quarter 2024 Financial Results and Business Highlights Form 8 K - Marketscreener.com

Nov 12, 2024
pulisher
Nov 12, 2024

Aura Biosciences Reports Third Quarter 2024 Financial Results and Business Highlights - GlobeNewswire

Nov 12, 2024
pulisher
Nov 12, 2024

Aura Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024
pulisher
Nov 12, 2024

Aura Biosciences, Inc. (NASDAQ:AURA) Receives Average Rating of "Buy" from Analysts - MarketBeat

Nov 12, 2024
pulisher
Nov 01, 2024

Aura Biosciences, Inc. (NASDAQ:AURA) Short Interest Update - Defense World

Nov 01, 2024
pulisher
Oct 31, 2024

One Aura Biosciences Insider Raised Stake By 232% In Previous Year - Yahoo Finance

Oct 31, 2024
pulisher
Oct 30, 2024

Short Interest in Aura Biosciences, Inc. (NASDAQ:AURA) Decreases By 8.7% - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

Aura Biosciences, Inc. (NASDAQ:AURA) Insider Sells $98,808.00 in Stock - MarketBeat

Oct 30, 2024
pulisher
Oct 29, 2024

Aura Biosciences VP sells shares worth $5,938 By Investing.com - Investing.com Australia

Oct 29, 2024
pulisher
Oct 29, 2024

Aura Biosciences CEO Elisabet de los Pinos sells $98,787 in stock By Investing.com - Investing.com South Africa

Oct 29, 2024
pulisher
Oct 29, 2024

Aura Biosciences CEO Elisabet de los Pinos sells $98,787 in stock - Investing.com

Oct 29, 2024
pulisher
Oct 29, 2024

Aura Biosciences VP sells shares worth $5,938 - Investing.com

Oct 29, 2024
pulisher
Oct 23, 2024

Don't Ignore The Insider Selling In Aura Biosciences - Simply Wall St

Oct 23, 2024
pulisher
Oct 23, 2024

Aura Biosciences (NASDAQ:AURA) Stock Price Down 4.9% After Insider Selling - Defense World

Oct 23, 2024
pulisher
Oct 22, 2024

Aura Biosciences CFO Julie Feder sells shares worth $302,361 - Investing.com India

Oct 22, 2024
pulisher
Oct 22, 2024

Aura Biosciences (NASDAQ:AURA) Trading Down 4.9% on Insider Selling - MarketBeat

Oct 22, 2024
pulisher
Oct 21, 2024

Aura Biosciences, Inc. (NASDAQ:AURA) CFO Sells $302,325.93 in Stock - MarketBeat

Oct 21, 2024
pulisher
Oct 21, 2024

Aura Biosciences: 2 Positive Bel-Sar Data Releases Brings Shareholder Value - Seeking Alpha

Oct 21, 2024
pulisher
Oct 21, 2024

Aura Biosciences, Inc. (NASDAQ:AURA) Receives $23.00 Average Price Target from Analysts - Defense World

Oct 21, 2024
pulisher
Oct 20, 2024

Long Term Trading Analysis for (AURA) - Stock Traders Daily

Oct 20, 2024
pulisher
Oct 20, 2024

Aura Biosciences (NASDAQ:AURA) PT Raised to $22.00 at HC Wainwright - Defense World

Oct 20, 2024
pulisher
Oct 19, 2024

Aura Biosciences stock hits 52-week high at $12.38 By Investing.com - Investing.com Australia

Oct 19, 2024
pulisher
Oct 19, 2024

Aura Biosciences CEO sells $300,838 in stock By Investing.com - Investing.com Australia

Oct 19, 2024
pulisher
Oct 19, 2024

Aura Biosciences reports promising early trial results - Investing.com India

Oct 19, 2024
pulisher
Oct 18, 2024

Insider Selling: Aura Biosciences, Inc. (NASDAQ:AURA) Insider Sells 24,992 Shares of Stock - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

Aura Biosciences CEO sells $300,838 in stock - Investing.com

Oct 18, 2024
pulisher
Oct 18, 2024

Aura Biosciences, Inc. (NASDAQ:AURA) Given Average Recommendation of "Buy" by Analysts - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

Aura Biosciences' Shares Touch 52-Week High on Positive Cancer Drug Data - MarketWatch

Oct 18, 2024
pulisher
Oct 18, 2024

Aura Biosciences (NASDAQ:AURA) Hits New 12-Month High After Analyst Upgrade - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

Aura Biosciences stock hits 52-week high at $12.38 - Investing.com

Oct 18, 2024
pulisher
Oct 18, 2024

Aura Biosciences stock maintains Buy rating on promising trial results By Investing.com - Investing.com Canada

Oct 18, 2024
pulisher
Oct 18, 2024

Aura Biosciences' Bladder Cancer Candidate Demonstrates Tumor Shrinkage In Patients With High-Grade Disease - Benzinga

Oct 18, 2024
pulisher
Oct 18, 2024

Aura Biosciences (NASDAQ:AURA) Price Target Increased to $23.00 by Analysts at Scotiabank - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

Aura Biosciences stock price target up 5%, H.C. Wainwright rates Buy after virtual oncology event - Investing.com Canada

Oct 18, 2024
pulisher
Oct 18, 2024

Aura Biosciences Shares Surge After-Hour On Positive Clinical Trial Results - Stocks Telegraph

Oct 18, 2024
pulisher
Oct 17, 2024

Multiple Clinical Complete Responses Demonstrated Following - GlobeNewswire

Oct 17, 2024
pulisher
Oct 17, 2024

Aura Biosciences Reports Positive Phase 1 Trial Results - TipRanks

Oct 17, 2024
pulisher
Oct 17, 2024

Multiple Clinical Complete Responses Demonstrated Following Single Low Dose Administration of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) in Ongoing Phase 1 Trial - The Manila Times

Oct 17, 2024
pulisher
Oct 17, 2024

Aura Biosciences reports promising early trial results By Investing.com - Investing.com UK

Oct 17, 2024

Aura Biosciences Inc (AURA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$19.00
price up icon 4.27%
$76.98
price up icon 1.23%
$39.53
price up icon 7.03%
$359.21
price down icon 0.88%
$187.76
price down icon 0.58%
$101.83
price up icon 2.00%
자본화:     |  볼륨(24시간):